Using hospitalization rates to track the economic costs and benefits of improved diabetes care in the Americas

Diabetes Care

Volumn 23, Issue 12, 2000, Pages 1844-1846

  Gagliardino, Juan Joś ^a,c   Williams, Rhys ^b   Clark Jr , Charles M ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c REGENSTRIEF INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DIABETES MELLITUS; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; NOTE; PRACTICE GUIDELINE; QUALITY OF LIFE; RISK FACTOR;

EID: 0033646538     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.12.1844     Document Type: Note

References (36)

1. A Report of a Diabetes Health Economics Study Group
2. The burden of diabetes: Introductory remarks
3. The public health burden of diabetes and the reality of limits
4. Costs of temporary and permanent disability induced by diabetes
5. Outcomes and costs in diabetes care: Trends over three years
6. Excess costs of medical care for patients with diabetes in a managed care population
7. The effects of treatment on the direct costs of diabetes
8. Health care expenditures for people with diabetes mellitus
9. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
11. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
12. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes
13. Using practice guideline compendiums to provide better preventive care
14. Population-based assessment of the level of care among adults with diabetes in the U.S.
15. Survey of physician practice behaviors related to diabetes mellitus in the U.S.: Physician adherence to consensus recommendations
16. The changing face of macrovascular disease in noninsulin-dependent diabetes mellitus: An epidemic in progress
17. Global burden of diabetes, 1995- 2025
18. Prevention of type II (non-insulin dependent) diabetes by diet and physical exercise: The 6-year Malmo feasibility study
19. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study
20. Diabetes care and research in Europe: The Saint Vincent Declaration
21. The National Diabetes Education Program: Changing the way diabetes is treated
22. Declaration of the Americas on Diabetes:
23. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
24. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
25. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
26. Cholesterol lowering with Simvastatin improves prognosis of diabetic patients with coronary heart disease
27. Aspirin therapy in diabetes mellitus
28. DiabCare Quality Network in Europe: Telematics Project within the St. Vincent Declaration (Consensus Meeting), Athens, Greece, 28- 29 March 1995
29. PRODIABA: Programa de Prevencion, Atencion y Tratamiento del Paciente Diabetico: Frecuencia, causas y duracion de las intenciones de los pacientes diabeticos en hospitales publicos de la Provincia de Buenos Aires
30. Programa de Prevencion, Atencion y Tratamiento de Personas con Diabetes: Diseno e implementacion en una entidad financiadora de servicios de salud
31. Direct medical costs of complications resulting from type 2 diabetes in the U.S.